Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
暂无分享，去创建一个
J. Shah | M. Dimopoulos | S. Jagannath | P. Richardson | R. Benjamin | R. Hájek | X. Leleu | M. Gavriatopoulou | H. Auner | T. Facon | M. Mateos | M. Cavo | S. Shacham | I. Špička | N. Bahlis | M. Garg | A. Badros | Y. Chai | C. Venner | S. Delimpasi | Maryana Simonova | L. Pour | I. Kriachok | H. Pylypenko | V. Doronin | T. Dolai | D. Sinha | D. Stevens | H. Quach | M. Levy | Melina Arazy | M. Kauffman | S. Grosicki | L. Anderson | P. Moreau | G. Usenko | I. Spicka